Atorvastatin Calcium Hydrate/Cannabidiol

阿托伐他汀钙水合物/大麻二酚

Report date: 2025/07/30 16:21:37

Base Information

Drug NameAtorvastatin Calcium Hydrate/Cannabidiol
Drug Alias NameAtorvo
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsCannabinoid CB2 receptor inverse agonistsCannabinoid CB1 receptor inverse agonists +[5
TargetsHMG-CoA reductaseCannabinoid CB1 receptorCannabinoid CB2 receptor +[5
Therapy Area/IndicationsDyslipidemiasCoronary Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIndication Bioscience LLC
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDyslipidemiasCoronary Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A